Bosutinib 100 mg is a targeted therapy used to treat Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) by slowing the growth of cancer cells.
| |||||||||||||||||||||
Bosutinib 100 mg Australia
Price range: $94.00 through $257.00
Reviews (0)
| |||||||||||||||||||||
Price range: $94.00 through $257.00
Bosutinib 100 mg is a targeted therapy used to treat Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) by slowing the growth of cancer cells.
There are no reviews yet.